We are live on ! Find out more
HHAA

Henry H. Armstrong Associates Portfolio holdings

AUM $1.03B
1-Year Est. Return 4.23%
This Fund
S&P 500
This Quarter Est. Return
-6.98%
1 Year Est. Return
+4.23%
3 Year Est. Return
+49.29%
5 Year Est. Return
+75.36%
10 Year Est. Return
+299.63%
AUM
$738M
AUM Growth
-$54.9M
Cap. Flow
+$4.33M
Cap. Flow %
0.59%
Top 10 Hldgs %
86.98%
Holding
63
New
1
Increased
24
Reduced
10
Closed
3

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$232K
2
AMGN icon
Amgen
AMGN
+$218K
3
CVX icon
Chevron
CVX
+$217K
4
WBA
Walgreens Boots Alliance
WBA
+$213K
5
KO icon
Coca-Cola
KO
+$134K

Sector Composition

Rank Sector Weight
1 Financials 39.12%
2 Technology 29.6%
3 Healthcare 14.36%
4 Consumer Staples 9.74%
5 Communication Services 2.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNA icon
51
CareDx
CDNA
$2.44B
$273K 0.04%
16,036
DAR icon
52
Darling Ingredients
DAR
$9.91B
$269K 0.04%
4,070
WMT icon
53
Walmart Inc
WMT
$897B
$248K 0.03%
5,742
-369
-6% -$16.2K
SHW icon
54
Sherwin-Williams
SHW
$88.1B
$246K 0.03%
1,200
GLW icon
55
Corning
GLW
$136B
$245K 0.03%
8,450
MRK icon
56
Merck
MRK
$323B
$241K 0.03%
2,795
IVV icon
57
iShares Core S&P 500 ETF
IVV
$904B
$224K 0.03%
625
KMB icon
58
Kimberly-Clark
KMB
$35.9B
$224K 0.03%
1,986
RTX icon
59
RTX Corp
RTX
$302B
$212K 0.03%
2,590
AMGN icon
60
Amgen
AMGN
$226B
-896
Closed -$218K
CVX icon
61
Chevron
CVX
$382B
-1,500
Closed -$217K
NVDA icon
62
NVIDIA
NVDA
$5.27T
-15,280
Closed -$232K

Similar funds

Henry H. Armstrong Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Henry H. Armstrong Associates held 63 positions worth $738M, down 6.9% from $793M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Henry H. Armstrong Associates's Q3 2022 filing shows 1 new, 24 increased, 10 reduced and 3 closed positions. Its largest new stake was Novo Nordisk: 17,410 shares worth $867K. The largest sale was NVIDIA, an estimated $232K.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 37% a quarter earlier, followed by Technology and Healthcare.

  • Henry H. Armstrong Associates's largest Q3 2022 buy was Novo Nordisk: 17,410 shares worth $867K.
  • Henry H. Armstrong Associates added most to Berkshire Hathaway Class A in Q3 2022, an estimated $1.28M increase.
  • Henry H. Armstrong Associates's biggest Q3 2022 reduction was Walgreens Boots Alliance, cutting an estimated $213K.
  • Henry H. Armstrong Associates fully exited NVIDIA in Q3 2022, selling an estimated $232K.
  • Henry H. Armstrong Associates's ten largest holdings make up 87% of its $738M portfolio in Q3 2022.
  • Henry H. Armstrong Associates opened 1 new position and closed 3 in Q3 2022.
  • Henry H. Armstrong Associates's portfolio value fell 6.9% quarter-over-quarter to $738M.

Based on Henry H. Armstrong Associates's 13F filing for Q3 2022, filed 12 Oct 2022.